RUNX2 and osteosarcoma: RUNX2 establishes osteoblasts in a terminally differentiated state through cooperation with retinoblastoma tumor suppressor protein (pRb) and cyclin-dependent kinase inhibitor p27KIP1, and disruption of this cooperation is associated with dedifferentiation in high-grade osteosarcomas [40].